Table 3.
Reference | |||
---|---|---|---|
Phase 1 | Earlier breakthrough | Familial PBC | (4) |
Twin concordance | (98) | ||
Risk factors | (9) | ||
Phase 2 | Later developments | HLA/non-HLA associations | (99) |
X chromosome defects | (100) | ||
Bacterial candidates | (101) | ||
Xenobiotic reactivity | (56) | ||
Phase 3 | What is next? | Genome-wide association studies | |
Spontaneous animal models | |||
Epigenetic studies | |||
Recapitulation of bacteria and chemicals |